Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells
about
Megalin in acute kidney injury: foe and friendPediatric acute kidney injury: A syndrome under paradigm shiftRecent insights into the biological functions of liver fatty acid binding protein 1Structural and functional interaction of fatty acids with human liver fatty acid-binding protein (L-FABP) T94A variantFatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal DiseasesSilencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease.Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury.Acute kidney injury after using contrast during cardiac catheterization in children with heart diseaseDietary heme-mediated PPARα activation does not affect the heme-induced epithelial hyperproliferation and hyperplasia in mouse colonAblating L-FABP in SCP-2/SCP-x null mice impairs bile acid metabolism and biliary HDL-cholesterol secretion.Epidermal fatty acid-binding protein protects nerve growth factor-differentiated PC12 cells from lipotoxic injuryRenal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications.Iron dextran increases hepatic oxidative stress and alters expression of genes related to lipid metabolism contributing to hyperlipidaemia in murine modelHepatoprotective role of liver fatty acid binding protein in acetaminophen induced toxicity.Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis.Marking renal injury: can we move beyond serum creatinine?An Atherogenic Paigen-Diet Aggravates Nephropathy in Type 2 Diabetic OLETF RatsLoss of L-FABP, SCP-2/SCP-x, or both induces hepatic lipid accumulation in female miceEffects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating tLoss of intracellular lipid binding proteins differentially impacts saturated fatty acid uptake and nuclear targeting in mouse hepatocytesEpoetin beta pegol alleviates oxidative stress and exacerbation of renal damage from iron deposition, thereby delaying CKD progression in progressive glomerulonephritis ratsRole of new biomarkers: functional and structural damageDo PPARgamma Ligands Suppress the Growth of Cholangiocarcinoma or the Cholangiohepatitis Induced by the Tumor?Susceptibility of L-FABP-/- mice to oxidative stress in early-stage alcoholic liver.Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma.Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury.Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage.Identification of biomarkers associated with the development of hepatocellular carcinoma in CuZn superoxide dismutase deficient miceLiver Fatty Acid Binding Protein Deficiency Provokes Oxidative Stress, Inflammation, and Apoptosis-Mediated Hepatotoxicity Induced by Pyrazinamide in Zebrafish LarvaeMolecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity.Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS).Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice.Acute kidney injury in acute on chronic liver failure.Acute-on-chronic liver failure: recent update.Biomarkers in acute kidney injury - pathophysiological basis and clinical performance.Asymmetric dimethylarginine and heart-type fatty acid-binding protein 3 are risk markers of cardiotoxicity in carbon monoxide poisoning cases in Zagazig university hospitals.Nano-LC-MS/MS based proteomics of hepatocellular carcinoma cells compared to Chang liver cells and tanshinone IIA induction.Regulation of liver fatty acid binding protein expression by clofibrate in hepatoma cells.
P2860
Q26823048-71E3C5DA-0BCF-412E-A949-C27FCEC28F35Q27024304-72F1E0CE-C65E-474D-A9A1-4BDD84703F10Q28268205-C867412C-49AF-4F3C-9CD6-15A72787F865Q33581953-E7B502E1-30F6-41A2-8865-FDD32799FCC5Q33613330-AE092B59-6786-4797-9215-3113D863686BQ33838866-0F4E1D53-D0A6-4E08-AE7E-DEFDC4D2FB33Q33862990-57BE3BB8-A2B4-446B-AF37-D57CC3E95F32Q33894710-42794E2F-105F-4FB4-BF59-52C9B8587EAAQ34029969-46314DAA-44D2-43D5-B711-625ED6C49353Q34384927-B79A4E62-97D4-46A6-A582-EE71CFBAACB8Q34627512-74B18230-F938-4028-BC34-C5C4D969F870Q34734555-DD444796-A7AD-4D25-889F-9D6F417B69C9Q34760887-EFAD78F2-096D-4D23-ABB8-C17593C3D84CQ34828809-78C543E9-A49E-4E61-A051-4E1936DCA9A2Q35037636-7DB0B45D-B8AD-47E2-8BC9-24A96432BD9CQ35114156-BC8D8F21-9309-4A3A-8E08-3D6215804C60Q35468668-4B4D6E5A-5356-4691-8CA3-5BD7EBF41231Q35841388-9F51365D-A5CF-4B4C-B165-4B9A0678655FQ35852316-AD88081D-B20D-47E4-B5B9-FBF8392C2B9EQ35911451-5DA0755C-E7D8-4608-BEA0-743DE6343B8FQ36086582-2B9B23D6-A8ED-4BB2-B982-74B1042CDD1EQ36312374-794713FB-5CD0-4A35-B7B8-6A104FBD728FQ36597896-63CD9941-7D37-48EE-B147-E22CBD6BC08FQ36622423-7086714F-63C9-45F5-937F-635688C32488Q36743971-28B68DEE-0201-4F93-BEAF-2227B05BB009Q36754807-313477F7-3E77-4CCA-A835-9A758A365920Q37109719-C010D3DD-B8AC-4F06-B8AD-4685E196EB94Q37164509-D4DFA7A8-AF9B-4F2A-9589-9CAF3BDEA55CQ37197335-4602A8AD-4FA7-4ED0-809B-95636406BFF8Q37312829-15450747-F8CD-4F66-9401-15323DD50EA3Q37428683-39263A88-5B96-4E87-83FF-F87C932AA539Q37430604-35FA5FBA-EC0C-4B7C-90FF-397181D922C2Q37684606-DCFAE07F-5DC1-4F6F-BA58-14CA5AFA65BAQ37866846-8D4247DE-54A2-4B97-B49B-ACFC9315B7D7Q38608226-895B5801-7937-4A44-A1B0-DF4258BB0745Q38698971-FFEF661E-2D5D-48B7-A0AA-05BEFE02D627Q38836197-B028343F-42CD-4171-82B3-5424ADBB9E54Q38852297-E82DDB71-DC8E-408C-B756-96F7A3012CCAQ39572850-D7B1F848-54D4-45C8-BFA5-A25F5DF54690Q39628443-493E9164-5E7D-4C17-8520-2D7538663561
P2860
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells
@ast
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells
@en
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells
@en-gb
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells
@nl
type
label
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells
@ast
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells
@en
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells
@en-gb
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells
@nl
prefLabel
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells
@ast
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells
@en
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells
@en-gb
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells
@en
P2093
Dongfeng Sun
Gerald Minuk
Judy Anderson
P2860
P304
P3181
P356
10.1002/HEP.20857
P407
P577
2005-10-01T00:00:00Z